Xprestest INC.
- UEI
- CJM8UNDHJ2N7
- SAM.gov registration
- Not checked yet
- Parent company
- Xwell INC.
- Physical address
- 254 W 31ST ST, STE 11TH, NEW YORK, NY 10001
Forensic summary
XPRESTEST INC. is a company based in New York, New York, and is affiliated with XWELL INC. According to our records, the company has one contract in our database, which was awarded on July 6, 2026. The majority of its federal contracting activity, totaling $18.8 million, is associated with the Department of Health and Human Services. The company operates primarily in the field of other scientific and technical consulting services, as indicated by its top industry classification.
XPRESTEST INC. has a risk score of 0, indicating a low risk profile. Our analysis found no risk indicators in the data available to us. This score is based on the information in our database and does not reflect the company's full history or operations outside of our records.
Written by AI only from the data on this page. Check the linked sources before relying on it.
Risk indicators
No risk indicators found in the records we hold.
The score adds up statistical indicators from public records. It is a prompt for review, not evidence of wrongdoing.
Stock market and financials (SEC)
Part of the Xwell, INC. group, which is publicly traded · XWEL · SEC EDGAR
| Fiscal year | Revenue | Net income | Operating cash flow | Assets | Equity | Long-term debt |
|---|---|---|---|---|---|---|
| 2025 | $29.2M | -$17M | -$8.7M | — | — | — |
| 2024 | $33.9M | -$16.9M | -$11M | $25.4M | -$788K | — |
| 2023 | $30.1M | -$27.7M | -$16.1M | $39M | $13M | — |
| 2022 | $55.9M | -$32.8M | -$24.2M | $70.4M | $39.9M | — |
| 2021 | $73.7M | $3.3M | $14.6M | $127.3M | $92.7M | — |
Material events (8-K), last 3 years
- Oct 20, 2026 8-K · Delisting noticeto verify
- Oct 8, 2026 8-K · Material agreement
- Aug 5, 2026 8-K · Director or officer change, Regulation FD disclosure
- Jul 9, 2026 8-K · Material agreement, Regulation FD disclosure
- Apr 10, 2026 8-K/A · Shareholder vote
- Apr 1, 2026 8-K · Results of operations
- Mar 4, 2026 8-K · Material agreement, Unregistered sale of equity, Modification of shareholder rights, Amendment to bylaws
- Feb 25, 2026 8-K · Material agreement, Unregistered sale of equity, Director or officer change, Amendment to bylaws, Other events
- Dec 18, 2025 8-K · Shareholder vote
- Dec 5, 2025 8-K · Delisting noticeto verify
- Nov 14, 2025 8-K · Results of operations
- Nov 14, 2025 8-K · Modification of shareholder rights, Amendment to bylaws
Annual figures from official SEC filings (XBRL). Dependence compares federal contracts signed by group companies in the last 12 months (total contract value, which may span several years) with the latest annual revenue: a reference, not an accounting figure. Stock prices are not included.
Digital presence and cybersecurity
vringoip.com · group website (Wikidata)
The homepage could not be read (it blocks automated visits or did not respond): the grade is based on email protection only.
- ✗ SPF no record
- ✗ DMARC no record
Passive check on Oct 29, 2026: only what any browser sees when opening the homepage and what the domain publishes in DNS (no scans or probing). It is a baseline best-practice reference, not a security audit; a missing header does not imply a vulnerability.
Linked entities
Links come from shared physical addresses, reported executives and parent companies. A link is not an accusation.
Contract history
| Award | Agency | Description | Signed | Obligated | Mods | Obligated / ceiling | Competition |
|---|---|---|---|---|---|---|---|
| 75D30126C21193 | Centers For Disease Control And Prevention | EBOLA ENTRY SCREENING SERVICES EO 14398 | Jul 6, 2026 | $18,815,411 | 2 | ×0.53 | Not competed |